A high flavonol intake could lower the risk for Alzheimer’s dementia

A high flavonol intake could lower the risk for Alzheimer’s dementia

Dementia patients being admitted to hospital for emergencies up by 35 percent The participants were divided into five groups based on their intake of four flavonols: kaempferol, quercetin, myricetin, and isorhamnetin. Those in the lowest quintile for flavonol intake consumed an average of 5.3 mg per day, compared with 15.3 mg per day among those in the highest quintile. People in the highest quintile for overall flavonol intake were at a 48% lower risk After adjustment for factors that could influence Alzheimer’s risk such as genetic predisposition, physical activity level and health conditions such as diabetes and stroke, people in the highest quintile for overall flavonol intake were at a 48% lower risk of developing Alzheimer’s dementia than those in the lowest quintile. Of 186 people in the top quintile, 28 (15%) developed the condition, compared with 54 of 182 (30%) in the bottom quintile. When the team analyzed the participants’ intake of the four flavonol subtypes, they found that people with the highest versus lowest intake of either isorhamnetin (found in pears, tomato sauce, olive oil, and wine) or myricetin (found in tea, wine, oranges, tomatoes, and kale) were at a 38% lower risk for developing Alzheimer’s and those with the highest intake of kaempferol (found in tea, beans, spinach, kale, and broccoli) were at a 51% lower risk. The bioactives in foods -- which from our research would be specifically flavonols found in kale, spinach, tomatoes, tea, olive oil, apples, pears, and over 20 other foods -- have antioxidant and anti-inflammatory properties that have the potential to protect against cellular damage due to oxidative stress and sustained inflammation.” Holland The team acknowledges several limitations to the study, including potential residual confounding, an observational design and participants’ self-reporting of food intake. Holland also notes that the study was not designed to prove cause and effect and only points to an association between flavonol intake and the risk for Alzheimer's dementia. However, in communications with The Jerusalem Post, Holland advised people to eat fruits and vegetables, particularly dark leafy greens, and to drink some tea now and again: “A healthy diet that contains various fruits and vegetables is critical for continued health, especially brain health,” he concluded. Sources: TreeHugger. (2020). 11 foods linked to lower risk of Alzheimer's dementia. [online] Available at: https://www.treehugger.com/health/11-foods-and-drinks-linked-lower-risk-alzheimers-dementia.html [Accessed 30 Jan. 2020]. dementia, A. (2020). Study: Antioxidant flavonol linked to lower risk of Alzheimer's dementia. [online] Medicalxpress.com. Available at: https://medicalxpress.com/news/2020-01-antioxidant-flavonol-linked-alzheimer-dementia.html [Accessed 30 Jan. 2020]. The Jerusalem Post | JPost.com. (2020). Fruits, vegetables, tea consumption linked with lower Alzheimer's risk. [online] Available at: https://www.jpost.com/HEALTH-SCIENCE/Fruits-vegetables-tea-consumption-linked-with-lower-Alzheimers-risk-615887 [Accessed 30 Jan. 2020]. Judy George (2020). More Flavonol, Less Alzheimer's. [online] Medpagetoday.com. Available at: https://www.medpagetoday.com/neurology/alzheimersdisease/84603 [Accessed 30 Jan. 2020].



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More